Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Deffered Revenue (2022)

Roivant Sciences' Non-Current Deffered Revenue history spans 1 years, with the latest figure at $11.9 million for Q3 2022.

  • For Q3 2022, Non-Current Deffered Revenue changed N/A year-over-year to $11.9 million; the TTM value through Sep 2022 reached $11.9 million, changed N/A, while the annual FY2022 figure was $13.7 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue reached $11.9 million in Q3 2022 per ROIV's latest filing, down from $13.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $13.7 million in Q1 2022 to a low of $11.9 million in Q3 2022.